87 results
Page 3 of 5
424B3
96z2w20h gvdfcufej
28 Jun 21
Prospectus supplement
9:18am
424B3
21f5te2 06gpj7ui2n
28 Jun 21
Prospectus supplement
9:17am
6-K
EX-99.1
647te78ewp12w96zp
28 Jun 21
Current report (foreign)
9:16am
F-4
hguvx 4zb
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
2vc5y1dp
3 Jun 21
Prospectus supplement
6:06am
424B3
wusuv
3 Jun 21
Prospectus supplement
6:06am
6-K
EX-99.1
lmudfa26u56k
3 Jun 21
FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
6:03am
424B3
r5xqvzhocf
2 Jun 21
Prospectus supplement
10:10am
424B3
epxl6wc7uql yppy
2 Jun 21
Prospectus supplement
10:09am
424B3
stk6ajrffqn
2 Jun 21
Prospectus supplement
10:08am
425
la4ontqdf3s3v
5 May 21
Business combination disclosure
5:27pm
6-K
EX-99.1
4iuwudi0
5 May 21
Agreement and Plan of Merger
5:19pm
20-F
heqkc
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.3
4tkb3tui
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.5
9q2q m5zksz
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
424B3
d1xt4zq
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
ov7r114pzln 1of2089
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
424B4
0o9p08sr1974lslfc fk
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
6k64pk4sjl
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
clxmcks3yij6 esz9ygr
8 Jan 21
Registration statement (foreign)
4:58pm